By combining anti-CD47 mAb with ani-PD-L1 mAb, the promotion of tumor cell phagocytosis in vitro was obtained as well as suppression of growth of the tumor observed in vivo, which showed the synergy between innate and adaptive ICIs [159]. Here, CD47 is linked to neoplasm.